Clinical Trial Update: Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of a grass pollen sublingual tablet in children and adolescents with rhinoconjunctivitis/rhinitis has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Grass pollen sublingual tablet (grass pollen allergen extract (sublingual tablet))

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Rhinoconjunctivitis, Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-07